Genedrive wins extra grant funding for NHS genetic testing
(Alliance News) - Genedrive PLC on Wednesday announced follow-on funding of GBP200,000 for further improvements to user experiences in rapid genetic testing environments. Read More
Price | 1.49p on 21-04-2025 | at 04:45:10
---|---|
Change | 0.00p 0% |
Buy | 1.50p |
Sell | 1.48p |
Buy / Sell GDR Shares |
Last Trade: | Buy 15,536.00 at 1.50p |
Day's Volume: | 0 |
Last Close: | 1.49p |
Open: | 0.00p |
ISIN: | GB00B1VKB244 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 1.425p - 7.25p |
Market Capitalisation: | £8m |
VWAP: | 0.00p |
Shares in Issue: | 543m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Genedrive (GDR) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 15,536 | 1.50p | Ordinary |
16:22:11 - 17-Apr-25 |
Buy* | 26,271 | 1.4997p | Ordinary |
16:08:48 - 17-Apr-25 |
Buy* | 66,414 | 1.4997p | Ordinary |
16:02:33 - 17-Apr-25 |
Sell* | 125,000 | 1.5001p | Ordinary |
15:48:58 - 17-Apr-25 |
Sell* | 14,632 | 1.5001p | Ordinary |
15:33:39 - 17-Apr-25 |
Buy* | 13,211 | 1.5064p | Ordinary |
14:25:15 - 17-Apr-25 |
Sell* | 333,508 | 1.501p | Ordinary |
14:21:08 - 17-Apr-25 |
Sell* | 295,420 | 1.5035p | Ordinary |
14:05:44 - 17-Apr-25 |
Sell* | 33,652 | 1.5035p | Ordinary |
13:12:31 - 17-Apr-25 |
Buy* | 331,286 | 1.5064p | Ordinary |
12:59:46 - 17-Apr-25 |
Genedrive (GDR) Regulatory News |
||
Date | Source | Headline |
---|---|---|
2nd Apr 2025 7:01 am | RNS | Additional grant funding under DEVOTE programme |
2nd Apr 2025 7:00 am | RNS | Receipt of R&D tax credit |
1st Apr 2025 7:00 am | RNS | Result of RetailBook Offer |
27th Mar 2025 3:30 pm | RNS | RetailBook Offer |
27th Mar 2025 3:29 pm | RNS | Half-year Report |
27th Mar 2025 3:28 pm | RNS | Equity Fundraise |
17th Mar 2025 11:04 am | RNS | Scottish Government testing programme investment |
14th Mar 2025 7:00 am | RNS | CYP2C19-ID Kit adopted for routine clinical use |
30th Dec 2024 11:54 am | RNS | Result of AGM |
27th Dec 2024 7:00 am | RNS | Genedrive® CYP2C19-ID Kit performance published |